Five Directors at Alkaloid AD Skopje bought 931 shares at 0.000MKD. The significance rating of the trade was 62/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...
HEADLINES: • Otokar: weak set of 3Q24 results NEGATIVE • Piraeus Financial Holdings: 3Q24 highlights – decent quarter, with revised guidance POSITIVE • Brisa: profitability should return in 4Q, on October price hikes NEUTRAL • Elm: strong 3Q24 financial results POSITIVE • Jahez: strong 3Q24 results POSITIVE • Alkaloid AD Skopje: strong 3Q24 sales and a qoq margin rebound POSITIVE • EME Macro/Strategy: macro all-in-one (28 October-3 November) • Magyar Telekom: reaches agreement with the trade uni...
EME Equity Market – October 2024 A red October for the EME indices, only Czechia in positive territory. The MSCI EM Europe Index declined by 6.0% in EUR terms and 8.4% in USD terms in October. The Czech PX index was the only one spared, adding 1.3% mom in EUR terms. Türkiye was battered the most, with the Turkish ISE30 declining by 7.3% mom in EUR terms, followed closely by the Polish WIG20 (-6.7% mom in EUR terms). Greece fell 4.8% mom in EUR terms, while the Hungarian BUX index lost 2.7% mom i...
Alkaloid has reported a solid set of numbers for 3Q24, with top-line growth of 17%, on strong domestic and international sales, particularly in Eastern Europe. Exports, in particular, were driven, we believe, by strong sales of its key antibiotic portfolio – an area where the company has invested heavily in new capacity in recent years – as well as its OTC portfolio. The latter represents the seasonal restocking of cold and flu drugs, and will likely continue through into 4Q. The EBITDA margin r...
EME Equity Market – July 2024 Greece the biggest winner, while Poland the clear loser in July. The MSCI EM Europe Index declined by 1.1% in EUR terms and 0.3% in USD terms in July. The Greek ASE Index posted the best performance for the month, advancing by 5.3% mom in EUR terms. There was a broadly similar performance in Hungary, Czechia and Romania (+ 2.9%, 2.7% and 2.1% mom in EUR terms, respectively). The Turkish ISE30 Index declined by 1.6% mom in EUR terms, but the clear loser was the Polis...
HEADLINES: • Solutions by STC: slower growth on the horizon (stays HOLD) • Wizz Air: 1Q FY25 – a miss, and FY guidance reviewed down NEGATIVE • mBank: posts solid 2Q24 results; evolution of the CHF mortgage saga a key catalyst NEUTRAL • Komercni Banka: 2Q24 results – slight miss • BRD-GSG: small miss on 2Q24 bottom line, but good dynamics in loan book development NEUTRAL • Eurobank Ergasias Services: 2Q24 highlights – in line in 2Q24, but trends indicate upside for full-year NI estimate • Euroba...
Alkaloid’s 2Q24 results keep the company on track to meet its FY24E earnings guidance – yoy EBITDA and net profit growth of 14% and 10%, respectively. A potential beat vs. the guidance is only likely to appear, in our view, in 4Q, on winter restocking and the first EU sales of its novel omeprazole formulation. In 2Q, revenues were affected positively by the first quarter of domestic sales for a government programme; the drugs supplied are: 1) rather expensive; but 2) low margin, as they are lice...
EME Equity Market – April 2024 Market performance – green across all geographies, with Turkey outperforming. The MSCI EM Europe Index was up 5.3% mom in EUR terms and 4.2% mom in USD in April; while the Turkish ISE30 saw the strongest performance, adding 11.6% mom; followed by the Hungarian BUX (+5.0% mom); the Czech PX (+2.8% mom); the Greek ASE (+1.8% mom), the Polish WIG20 (+1.2% mom) and the Romanian BET (+0.1% mom) (all in EUR terms).
HEADLINES: • CTP: better late than never (upgraded to BUY) • Georgia macro: protests in Tbilisi • Raiffeisen Bank International: posts solid 1Q24, keeps 2024E guidance (but only on ex. Russia and Belarus basis), facing huge pressure to address Russia and Belarus exposures from officials • Air Astana Group: 1Q24 – 15% ASK growth, RASK down slightly yoy, but CASK stable • Piraeus Financial Holdings: 1Q24 highlights NEUTRAL • Alkaloid: 1Q24 numbers a strong start to the year POSITIVE • National Ban...
Alkaloid reported another solid set of results in 1Q24, albeit with the yoy comparison on some lines coloured by the reclassification of cost from below to above the operating line. This quarter, the business caught a tailwind from cephalosporin antibiotic sales in Ukraine (the first quarter is typically strong for all antibiotics), but also from recent investments in its Western European markets. Keeping in mind seasonality, the company is well on track to meet its FY24E revenues growth target ...
EME Equity Market – March 2024 Market performance – mixed performances in March, with the Romanian BET outperforming. The MSCI EM Europe Index declined by 0.3% mom in EUR terms and 0.4% mom in USD in March. The Romanian BET reported the strongest performance, adding 7.1% mom in EUR terms, followed by the Czech PX and the Polish WIG20 (+4.1% and 1.0% mom, in EUR terms, respectively). Greece saw a relatively muted performance (-0.2% mom in EUR terms), while Hungary (-1.1% mom in EUR terms) and Tür...
HEADLINES: • Pegasus Airlines: 4Q23 – decent end to another very good year NEUTRAL • Ford Otosan: strong set of results in 4Q23 POSITIVE • ONE United Properties: FY23 – ramping up, with almost 1k units sold in 2023 • Alkaloid: 4Q23 – reaping the benefits of recent investments • Alkaloid: rating and price target changes • European oil and gas monthly: February 2024 – return of the crack • Transgaz: takeaways from the 4Q23 earnings call POSITIVE • Auto Partner: February sales growth accelerates...
There was an error in our flash note, published today. Please disregard the previous version. Last week, Alkaloid announced solid 4Q23 numbers, topping off the strong results for FY23. Most notably, the 4Q23 revenues grew by 22% yoy (+16% for FY23); this is despite a season slowdown in Russia/CIS. The growth was broad-based, with domestic sales and sales in Europe all up at least 20% yoy, reflecting recent investments in a new plant and products (both in pharmaceutics, as well as its FMCG busine...
Last week, Alkaloid announced solid 4Q23 numbers, topping off the strong results for FY23. Most notably, the 4Q23 revenues grew by 22% yoy (+16% for FY23); this is despite a season slowdown in Russia/CIS. The growth was broad-based, with domestic sales and sales in Europe all up at least 20% yoy, reflecting recent investments in a new plant and products (both in pharmaceutics, as well as its FMCG business). Supporting this was even higher spending on sales and marketing (+84% yoy in 4Q23), which...
HEADLINES: • Logo Yazilim: clearer skies in 2024E (stays BUY) • Turkish Airlines: 3Q23 - even better summer than last year POSITIVE • Brisa: solid 3Q23 results, on gross margin expansion and low CIT NEUTRAL • Migros: strong beat in the 3Q23 financials POSITIVE • ING BSK: posts solid 3Q23 results, but largely in line with its peers NEUTRAL • Verbund: 3Q23 results above our estimates • Alkaloid: 3Q revenues growth normalises, 4Q shaping up nicely NEUTRAL • EME Macro/Strategy: US - Fed stays on h...
EME Equity Market – October 2023 Market performance – election results prompt stellar market reaction in Poland; sell-off in Turkey. The MSCI EM Europe Index added 1.7% mom in EUR terms and 2.0% mom in USD in October. Poland staged a massive rebound, post the elections, with the WIG20 advancing 16.4% mom in EUR terms. Apart from Turkey, where October was a sell-off, with the ISE30 declining 13.7% mom in EUR terms, there were relatively muted performances everywhere else (BUX +2.1% / PX +0.4% / B...
Alkaloid has posted another solid set of results for 3Q23, with revenues growth normalising, after a brisk first half, but opex also contracting slightly, on lower sales and marketing costs (with doctors extending their summer holidays into September). Speaking to management, 4Q23E is shaping up to be solid as well, including Alkaloid’s target “growth” markets in the EU, but also on the domestic market: both are driven by new product launches, including new in- and out-licensing deals. To date, ...
EME Equity Market – July 2023 Market performance – gains keep on rolling in all geographies, with special mention of Turkey’s stellar performance. The MSCI EM Europe Index gained 8.6% mom in EUR terms and 9.5% mom in USD in July. Turkey clearly outperformed its peers, gaining 18.6% mom in EUR terms. Most other geographies performed more or less at similar levels, with the Polish WIG20 in the upper part of the range, advancing 7.3% mom in EUR terms, followed by the Romanian BET and Czech PX indic...
HEADLINES: • Garanti: 2Q23 highlights - in line with change of heart on discretionary provisions • Ford Otosan: 2Q23 financials - better-than-expected results POSITIVE • OMV: 2Q23 results - weak net income in 2Q23 • OMV Petrom: net loss in 2Q23, but lower than expected NEUTRAL • Borouge: 2Q23 results - in line • Alkaloid: 2Q23 - another strong quarter, with broad-based growth POSITIVE • Titan Cement: tailwinds from lower energy prices, construction demand POSITIVE • Mytilineos: CEO comfortabl...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.